MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF
Authors:
- Debbie M. BoetersDBDebbie M. Boeters
- Wouter P. NieuwenhuisWNWouter P. Nieuwenhuis
- Marije K. VerheulMVMarije K. Verheul
- Elize C. NewsumENElize C. Newsum
- Monique ReijnierseMRMonique Reijnierse
- René E. M. ToesRTRené E. M. Toes
- Leendert A. TrouwLTLeendert A. Trouw
- Annette H. M. van der Helm-Van MilAMAnnette H. M. van der Helm-Van Mil
Open Access
- 2 August 2016
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 18 (1) , 1-10
Abstract
In rheumatoid arthritis (RA) bone marrow edema (BME, osteitis) and anti-citrullinated protein antibodies (ACPA) are associated with radiographic progression. ACPA have been associated with BME, but it is unknown if this association is confined to ACPA and BME. We performed cross-sectional analysis of the association of ACPA, rheumatoid factor (RF) and anti-carbamylated protein (anti-CarP) antibodies with BME and other types of inflammation (synovitis, tenosynovitis) detected by magnetic resonance imaging (MRI). Disease-modifying antirheumatic drug (DMARD)-naïve patients with early arthritis (n = 589), included in the Leiden Early Arthritis Clinic cohort, underwent contrast-enhanced 1.5 T MRI of unilateral wrist, metacarpophalangeal and metatarsophalangeal-joints at baseline. BME, synovitis and tenosynovitis were scored by two readers. ACPA, rheumatoid factor (RF) and anti-CarP were determined at baseline. In univariable analyses ACPA-positive patients had higher BME scores than ACPA-negative patients (median 4.5 vs. 2.0, p < 0.001), but not more synovitis and tenosynovitis. Also RF (median 3.75 vs. 2.0, p < 0.001) and anti-CarP antibodies (median 3.5 vs. 2.5, p = 0.012) were associated with higher BME scores. Because the autoantibodies were concomitantly present, analyses were stratified for the presence of different autoantibody combinations. ACPA-positive (ACPA+), RF-negative (RF-), anti-CarP-negative (anti-CarP-) patients did not have higher BME-scores than ACPA-negative (ACPA-), RF-, anti-CarP- patients. However ACPA+, RF-positive (RF+), anti-CarP- patients and ACPA+, RF+, anti-CarP-positive (anti-CarP+) patients had higher BME scores than ACPA-, RF-, anti-CarP- patients (median 5.0 and 4.5 vs. 2.0, p < 0.001 and p < 0.001). ACPA levels were not associated with BME scores. Analyses within RA- and UA-patients revealed similar results. The presence of ACPA alone or ACPA level was not statistically significantly associated with BME scores, but the combined presence of ACPA and RF was associated with more BME. This suggests an additive role of RF to ACPA in mediating osteitis.Keywords
Funding Information
- Reumafonds
- Netherlands Organization for Health Research and Development (Vidi grant)
This publication has 47 references indexed in Scilit:
- Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanismAnnals of the Rheumatic Diseases, 2016
- Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activityAnnals of the Rheumatic Diseases, 2013
- Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspectiveArthritis Research & Therapy, 2012
- Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRIAnnals of the Rheumatic Diseases, 2011
- Toward a data‐driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: Is it sensible to look at levels of rheumatoid factor?Arthritis & Rheumatism, 2010
- Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive diseaseAnnals of the Rheumatic Diseases, 2009
- Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy studyRheumatology, 2006
- Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestationsAnnals of the Rheumatic Diseases, 2004
- The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritisArthritis & Rheumatism, 2000
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.Journal of Clinical Investigation, 1998